Valuation: InterCure Ltd.

Market Cap 178M 0 159M 147M 134M 251M 16.87B 255M 1.76B 693M 8.82B 668M 654M 28.18B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 314M 0 280M 259M 236M 443M 29.79B 450M 3.11B 1.22B 15.57B 1.18B 1.15B 49.78B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
61.79%
Yield 2024 *
-
Yield 2025 -
1 day-4.93%
1 week-9.16%
Current month-14.85%
1 month-12.98%
3 months-1.21%
6 months+24.50%
Current year-11.74%
1 week 1,401
Extreme 1401
1,599
1 month 1,401
Extreme 1401
1,701
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,621
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 67 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap. Importance
18/3/26 Other

Chief Financial Officer

539,947 0.9874%
18/3/26 Other

Director

19,046 0.0348%
18/3/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
-4.93%-9.16%-44.46%-41.25% 57.37M
-1.26%+3.81%+10.43%+28.99% 118B
-0.85%-0.76%+5.07%+86.48% 99.34B
+2.65%+1.38%+113.82%+873.38% 56.71B
-0.38%+6.42%-5.38%+81.83% 28.56B
+0.04%+0.75%+23.09%+90.81% 25.94B
-0.03%+0.51%+9.00%+59.01% 25.79B
-0.56%-1.13%+31.48%+370.90% 21.52B
-1.26%-3.69%-20.98%-3.86% 20.7B
+1.50%-2.87%+5.31%+87.23% 18.25B
Average -0.47%+0.01%+12.74%+163.35% 41.5B
Weighted average by Cap. -0.19%+2.41%+22.18%+186.15%

Financials

2024 2025
Net sales 239M 0 213M 197M 179M 336M 22.64B 342M 2.37B 930M 11.84B 896M 877M 37.83B 270M 0 241M 223M 203M 381M 25.62B 387M 2.68B 1.05B 13.39B 1.01B 993M 42.8B
Net income -67.8M -0 -60.43M -55.98M -50.9M -95.51M -6.43B -97.08M -671M -264M -3.36B -254M -249M -10.74B -35.71M -0 -31.83M -29.49M -26.81M -50.31M -3.39B -51.14M -354M -139M -1.77B -134M -131M -5.66B
Net Debt 133M 0 118M 110M 99.67M 187M 12.59B 190M 1.31B 517M 6.58B 498M 488M 21.03B 136M 0 122M 113M 102M 192M 12.93B 195M 1.35B 531M 6.76B 512M 501M 21.6B
Projected Income Statement - Annual - InterCure Ltd.
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
19/10/26 ILA 1,428.00 -4.93% 16,559
16/10/26 ILA 1,502.00 +0.74% 8,457
15/10/26 ILA 1,491.00 -1.19% 2,779
14/10/26 ILA 1,509.00 -1.69% 4,374
13/10/26 ILA 1,535.00 -2.35% 4,916
  1. Stock Market
  2. Stocks
  3. INCR Stock